BioCentury
ARTICLE | Clinical News

Adefovir dipivoxil nucleotide reverse transcriptase inhibitor regulatory update

November 8, 1999 8:00 AM UTC

The FDA's Antiviral Drugs Advisory Committee voted 13-1 against recommending approval for adefovir to treat HIV infection/AIDS (see BioCentury Extra, Nov. 2). The panel did say that the product could ...